838481002: Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Phosphotransferase inhibitor-containing product\Protein kinase inhibitor-containing product\Epidermal growth factor receptor antagonist antineoplastic agent\Trastuzumab deruxtecan-containing product\Trastuzumab deruxtecan-containing product in parenteral dose form\Trastuzumab deruxtecan only product in parenteral dose form
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Phosphotransferase inhibitor-containing product\Protein kinase inhibitor-containing product\Epidermal growth factor receptor antagonist antineoplastic agent\Trastuzumab deruxtecan-containing product\Trastuzumab deruxtecan only product\Trastuzumab deruxtecan only product in parenteral dose form
• \Medicinal product categorised by disposition\Immunomodulator-containing product\Trastuzumab deruxtecan-containing product\Trastuzumab deruxtecan-containing product in parenteral dose form\Trastuzumab deruxtecan only product in parenteral dose form
• \Medicinal product categorised by disposition\Immunomodulator-containing product\Trastuzumab deruxtecan-containing product\Trastuzumab deruxtecan only product\Trastuzumab deruxtecan only product in parenteral dose form
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Polypeptide-containing product\Protein-containing product\Antibody-containing product\Monoclonal antibody-containing product\Monoclonal antibody antineoplastic agent\Trastuzumab deruxtecan-containing product\...
• \Trastuzumab deruxtecan-containing product in parenteral dose form\Trastuzumab deruxtecan only product in parenteral dose form
• \Trastuzumab deruxtecan only product\Trastuzumab deruxtecan only product in parenteral dose form
• \Medicinal product categorised by therapeutic role\Antineoplastic agent\...
• \Monoclonal antibody antineoplastic agent\Trastuzumab deruxtecan-containing product\...
• \Trastuzumab deruxtecan-containing product in parenteral dose form\Trastuzumab deruxtecan only product in parenteral dose form
• \Trastuzumab deruxtecan only product\Trastuzumab deruxtecan only product in parenteral dose form
• \Epidermal growth factor receptor antagonist antineoplastic agent\Trastuzumab deruxtecan-containing product\...
• \Trastuzumab deruxtecan-containing product in parenteral dose form\Trastuzumab deruxtecan only product in parenteral dose form
• \Trastuzumab deruxtecan only product\Trastuzumab deruxtecan only product in parenteral dose form
• \Product manufactured as parenteral dose form\Trastuzumab deruxtecan-containing product in parenteral dose form\Trastuzumab deruxtecan only product in parenteral dose form

Status: current, Defined. Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
3897097014	Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
3897098016	Trastuzumab deruxtecan only product in parenteral dose form	en	Synonym	Active	Case insensitive	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start